drug protocol number

RFB002A2406

drug sponsor

Novartis

drug study

Ranibizumab 10mg/ml (Lucentis)

drug trial site

King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah), Prince Sultan Military Medical City (Riyadh)

drug status

Completed

drug phase